Updates in Neuropsychiatric Systemic Lupus Erythematosus: Advances in Pathogenesis, Diagnosis, and Therapies
- 1Department of Family Medicine, American University of Beirut Medical Center, Beirut, LBN
- 2Faculty of Medicine, Beirut Arab University, Beirut, LBN
Abstract
Neuropsychiatric systemic lupus erythematosus (NPSLE) encompasses a diverse range of neurological and psychiatric manifestations occurring in patients with systemic lupus erythematosus (SLE); however, these events are ultimately attributed to NPSLE only after rigorous exclusion of alternative etiologies and secondary causes. These manifestations result directly from lupus-related inflammation, vascular damage, or autoantibody effects on the central and peripheral nervous systems. The purpose of this review is to provide an updated overview of NPSLE, the multidisciplinary approach in diagnosing NPSLE, the different proposed mechanisms of pathophysiology, as well as the available treatment options. It also sheds light on the introduced advancements in personalized targeted therapy for NPSLE.
A comprehensive review of the relevant literature on the state of NPSLE diagnosis, pathogenesis, and treatment was conducted. Different search databases (PubMed, Google Scholar, ScienceDirect) were searched for studies published, prioritizing the most recent ones. Search terms included "neuropsychiatric manifestations of SLE", "diagnostic biomarkers", "targeted therapy", and "autoantibodies and neurotoxicity". Only English-language articles were included. As a narrative review, the selection was not systematic and may be subject to selection bias.
The review presented the most evident recent diagnostic approaches of NPSLE, including those currently in clinical use and those still under investigation. Moreover, the complex pathogenesis of autoantibodies, inflammatory cells, and cytokines, along with other environmental and genetic factors, was discussed. The emerging and promising strategies for NPSLE management targeting proposed or emerging pathogenic pathways offer new opportunities to treat one of the most severe complications of SLE.
The growing understanding of the pathogenesis of NPSLE paves the way for targeted therapy and symptom management. Despite promising advances, actual clinical trials are needed to evaluate the efficacy and safety of the proposed treatment strategies. Future research should focus on validating the personalized targeted interventions and ultimately improving prognosis and outcomes for patients suffering from this severe complication of NPSLE.
Related
- α-Ketoglutarate Alleviates the Pathogenesis of Systemic Lupus Erythematosus via Reducing Oxidative Stress and Attenuating Excessive Immune Response
- Low-level proteinuria at the initial diagnosis of systemic lupus erythematosus significantly increases the risk of developing proteinuria-predominant lupus nephritis
- Autophagy–Gut Microbiota–Epigenetic Interactions in Disease Pathogenesis: Focus on Neurodegenerative and Neuropsychiatric Disorders and Therapeutic Perspectives
- Fungal Pathogenesis at the Host–Pathogen Interface: Immune Recognition, Evasion, Antifungal Resistance, and Emerging Therapies
- Comparison Between Systemic Lupus Erythematosus Patients with and Without Family History of Systemic Lupus Erythematosus—A Single-Center Retrospective Study
BibTeX
@article{natour2026updates,
title = {{Updates in Neuropsychiatric Systemic Lupus Erythematosus: Advances in Pathogenesis, Diagnosis, and Therapies}},
author = {Dania El Natour and Yahya Makkieh and Taymour El Shaar and Hadi El Natour},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117661},
url = {https://doi.org/10.7759/cureus.117661},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Updates in Neuropsychiatric Systemic Lupus Erythematosus: Advances in Pathogenesis, Diagnosis, and Therapies
AU - Dania El Natour
AU - Yahya Makkieh
AU - Taymour El Shaar
AU - Hadi El Natour
PY - 2026
DA - 2026/10/08
JO - Cureus
DO - 10.7759/cureus.117661
UR - https://doi.org/10.7759/cureus.117661
AB - Neuropsychiatric systemic lupus erythematosus (NPSLE) encompasses a diverse range of neurological and psychiatric manifestations occurring in patients with systemic lupus erythematosus (SLE); however, these events are ultimately attributed to NPSLE only after rigorous exclusion of alternative etiologies and secondary causes. These manifestations result directly from lupus-related inflammation, vascular damage, or autoantibody effects on the central and peripheral nervous systems. The purpose of this review is to provide an updated overview of NPSLE, the multidisciplinary approach in diagnosing NPSLE, the different proposed mechanisms of pathophysiology, as well as the available treatment options. It also sheds light on the introduced advancements in personalized targeted therapy for NPSLE. A comprehensive review of the relevant literature on the state of NPSLE diagnosis, pathogenesis, and treatment was conducted. Different search databases (PubMed, Google Scholar, ScienceDirect) were searched for studies published, prioritizing the most recent ones. Search terms included "neuropsychiatric manifestations of SLE", "diagnostic biomarkers", "targeted therapy", and "autoantibodies and neurotoxicity". Only English-language articles were included. As a narrative review, the selection was not systematic and may be subject to selection bias. The review presented the most evident recent diagnostic approaches of NPSLE, including those currently in clinical use and those still under investigation. Moreover, the complex pathogenesis of autoantibodies, inflammatory cells, and cytokines, along with other environmental and genetic factors, was discussed. The emerging and promising strategies for NPSLE management targeting proposed or emerging pathogenic pathways offer new opportunities to treat one of the most severe complications of SLE. The growing understanding of the pathogenesis of NPSLE paves the way for targeted therapy and symptom management. Despite promising advances, actual clinical trials are needed to evaluate the efficacy and safety of the proposed treatment strategies. Future research should focus on validating the personalized targeted interventions and ultimately improving prognosis and outcomes for patients suffering from this severe complication of NPSLE.
SN - 2168-8184
ER -